Metabolisme Lipid: Biokimia, Regulasi, dan Korelasi Klinis

1. 1. Rodwell V.W., Bender D.A., Botham K.M., Kennelly P.J., Weil P.A.. Harper's Illustrated Biochemistry. McGraw-Hill Education (2018).
2. 2. Berg J.M., Tymoczko J.L., Gatto G.J., Stryer L.. Biochemistry. W.H. Freeman (2019).
3. 3. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI). Pedoman Tatalaksana Dislipidemia. PERKI (2021).
4. 4. Goldberg I.J., Eckel R.H., McPherson R.. Triglycerides and Heart Disease: The Next Frontier. Journal of the American College of Cardiology, 66(14), 1555–1567 (2015).
5. 5. Mach F., Baigent C., Catapano A.L., et al.. 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk. European Heart Journal, 41(1), 111–188 (2020).
6. 6. Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran (PNPK) Tata Laksana Dislipidemia. Kemenkes RI (2019).
7. 7. World Health Organization (WHO). WHO Guideline on Lipid-Modifying Agents for Cardiovascular Risk Management. WHO (2023).

Daftar pustaka untuk tujuan pendidikan. Verifikasi pedoman klinis terkini sebelum praktik.